Document:

Exhibit 10.1

	
  Named Executive Officer

  	
   

  	
  2007 Base Salary

  	
   

  	
  2007 Bonus Target

  	
   

  
	
  Henri A. Termeer

  Chief Executive Officer

  	
   

  	
  $

  	
  1,505,000

  	
   

  	
  $

  	
  1,785,000

  	
   

  
	
  Earl M. Collier, Jr.

  Executive Vice President

  	
   

  	
  $

  	
  537,000

  	
   

  	
  $

  	
  450,000

  	
   

  
	
  Georges Gemayel

  Executive Vice President

  	
   

  	
  $

  	
  490,000

  	
   

  	
  $

  	
  450,000

  	
   

  
	
  Peter Wirth

  Executive Vice President; Chief Legal Officer

  	
   

  	
  $

  	
  706,000

  	
   

  	
  $

  	
  450,000

  	
   

  
	
  Michael S. Wyzga

  Executive Vice President; Chief Financial Officer

  	
   

  	
  $

  	
  490,000

  	
   

  	
  $

  	
  450,000Exhibit 10.17

AMENDMENT NO. 2 to

EMPLOYMENT
AGREEMENT

This AMENDMENT NO. 2, dated as of December 6, 2006 (the “Amendment
No. 2”) to the EMPLOYMENT AGREEMENT
is by and between InterDent, Inc., a Delaware corporation (the “Company”),
and Ivar S. Chhina (the “Executive”).

WHEREAS,
the Company and the Executive are parties to that certain Employment Agreement,
effective as of October 9, 2003 (the “Employment Agreement”);

WHEREAS, the
Employment Agreement currently provides that its term extends through December
31, 2006; and

WHEREAS,
it is desired to extend the term of the Employment Agreement
until December 31, 2008;

NOW,
THEREFORE, the Company and the Executive hereby agree as
follows:

1.  The first paragraph of Section
1 is amended by replacing the words “December 31, 2006” with “December 31,
2008.”

2.  Section 2 is amended by
replacing the words “December 31, 2006” with “December 31, 2008.”

3. Section 20 is amended by replacing the words “O’Melveny & Myers
LLP, 400 South Hope Street” with the words “Pearl Meyer & Partners, 633 W.
Fifth Street, 52nd Floor.”

4. Counterparts.  This Amendment No. 2 may be executed in one
or more counterparts, each of which shall be deemed an original and all of
which together shall be considered one and the same agreement.

IN WITNESS
WHEREOF, the parties have executed this Amendment No. 2 as of
the date first above written.

	
  INTERDENT, INC.

  
	
  By:

  	
   

  	
  /s/ Robert Hill

  	
   

  
	
  Name:

  	
   

  	
  Robert Hill

  
	
  Title:

  	
   

  	
  CFO

  

 

	
  EXECUTIVE

  
	
  /s/ Ivar S. Chhina

  	
   

  
	
  Ivar S. ChhinaExhibit 10.1

EXECUTION
COPY

priceline.com
Incorporated

Common Stock, Par
Value $0.008 Per Share

Underwriting
Agreement

December 4, 2006

Goldman,
Sachs & Co.,

As
representative of the several Underwriters

named in Schedule I hereto,

c/o Goldman, Sachs & Co.
85 Broad Street,

New York, New York 10004.

Ladies and Gentlemen:

Certain
stockholders named in Schedule II hereto (the “Selling Stockholders”) of
priceline.com Incorporated, a Delaware corporation (the “Company”), propose,
subject to the terms and conditions stated herein, to sell to the Underwriters
named in Schedule I hereto (the “Underwriters”) an aggregate of 3,824,812
shares (the “Shares”) of common stock, par value $0.008 per share (“Stock”), of
the Company.

1.         The Company represents and warrants to,
and agrees with, each of the 
Underwriters that:

(a)         An
“automatic shelf registration statement” as defined under Rule 405 under the
Securities Act of 1933, as amended (the “Act”), on Form S-3 (File No.
333-139109) in respect of the Shares has been filed with the Securities and
Exchange Commission (the “Commission”) not earlier than three years prior to
the date hereof; such registration statement, and any post-effective
amendment thereto, became effective on filing; and no stop order suspending the
effectiveness of such registration statement or any part thereof has been
issued and no proceeding for that purpose has been initiated or threatened by
the Commission, and no notice of objection of the Commission to the use of such
registration statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the Act has been received by the Company (the base prospectus
filed as part of such registration statement, in the form in which it has most
recently been filed with the Commission on or prior to the date of this
Agreement, is hereinafter called the “Basic Prospectus”; any preliminary
prospectus (including any preliminary prospectus supplement) relating to the
Shares filed with the Commission pursuant to Rule 424(b) under the Act is
hereinafter called a

 

“Preliminary Prospectus”; the various parts of
such registration statement, including all exhibits thereto but excluding Form
T-1 and including any prospectus supplement relating to the Shares that is
filed with the Commission and deemed by virtue of Rule 430B under the Act to be
part of such registration statement, each as amended at the time such part of
the registration statement became effective, are hereinafter collectively
called the “Registration Statement”; the Basic Prospectus, as amended and
supplemented immediately prior to the Applicable Time (as defined in Section
1(c) hereof), is hereinafter called the “Pricing Prospectus”; the form of the
final prospectus relating to the Shares filed with the Commission pursuant to
Rule 424(b) under the Act in accordance with Section 5(a) hereof is hereinafter
called the “Prospectus”; any reference herein to the Basic Prospectus, the
Pricing Prospectus, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include the documents incorporated by reference therein
pursuant to Item 12 of Form S-3, as of the date of such prospectus; any
reference to any amendment or supplement to the Basic Prospectus, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include
any post-effective amendment to the Registration Statement, any prospectus
supplement relating to the Shares filed with the Commission pursuant to Rule
424(b) under the Act and any documents filed under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), and incorporated therein, in each
case after the date of the Basic Prospectus, such Preliminary Prospectus or the
Prospectus, as the case may be; any reference to any amendment to the
Registration Statement shall be deemed to refer to and include any annual
report of the Company filed pursuant to Section 13(a) or 15(d) of the Exchange
Act after the effective date of the Registration Statement that is incorporated
by reference in the Registration Statement; and any “issuer free writing
prospectus” as defined in Rule 433 under the Act relating to the Shares is
hereinafter called an “Issuer Free Writing Prospectus”;

(b)         No
order preventing or suspending the use of any Preliminary Prospectus or any
Issuer Free Writing Prospectus has been issued by the Commission, and each
Preliminary Prospectus, at the time of filing thereof, conformed in all
material respects to the requirements of the Act and the rules and regulations
of the Commission thereunder, and did not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any statements or omissions made
in reliance upon and in conformity with information furnished in writing to the
Company by an Underwriter through Goldman, Sachs & Co. expressly for use
therein;

(c)         For
the purposes of this Agreement, the “Applicable Time” is 5:00 p.m. (Eastern
time) on the date of this Agreement.  The
Pricing Prospectus, as of the Applicable Time, did not include any untrue
statement of a material fact or omit to state any material fact necessary in order
to make the statements therein, in the light of the circumstances under which
they were made, not misleading; and each Issuer Free Writing Prospectus listed
on Schedule III(a) hereto does not conflict with the

 2
 

 

information contained in the Registration
Statement, the Pricing Prospectus or the Prospectus and each such Issuer Free
Writing Prospectus, as supplemented by and taken together with the Pricing
Prospectus as of the Applicable Time, did not include any untrue statement of a
material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading; provided, however, that this representation and warranty
shall not apply to statements or omissions made in an Issuer Free Writing
Prospectus in reliance upon and in conformity with information furnished in
writing to the Company by an Underwriter through Goldman, Sachs & Co.
expressly for use therein;

(d)         The
documents incorporated by reference in the Pricing Prospectus and the
Prospectus, when they became effective or were filed with the Commission, as
the case may be, conformed in all material respects to the requirements of the
Act or the Exchange Act, as applicable, and the rules and regulations of the
Commission thereunder, and none of such documents contained an untrue statement
of a material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; and any
further documents so filed and incorporated by reference in the Prospectus or
any further amendment or supplement thereto, when such documents become
effective or are filed with the Commission, as the case may be, will conform in
all material respects to the requirements of the Act or the Exchange Act, as
applicable, and the rules and regulations of the Commission thereunder and will
not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading; provided, however, that this representation and warranty shall
not apply to any statements or omissions made in reliance upon and in
conformity with information furnished in writing to the Company by an
Underwriter through Goldman, Sachs & Co. expressly for use therein; and no
such documents were filed with the Commission since the Commission’s close of
business on the business day immediately prior to the date of this Agreement
and prior to the execution of this Agreement, except as set forth on Schedule
III(b) hereto;

(e)         The
Registration Statement conforms, and the Prospectus and any further amendments
or supplements to the Registration Statement and the Prospectus will conform,
in all material respects to the requirements of the Act and the rules and
regulations of the Commission thereunder and do not and will not, as of the
applicable effective date as to each part of the Registration Statement and as
of the applicable filing date as to the Prospectus and any amendment or
supplement thereto, contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the
statements therein not misleading; provided, however, that this representation
and warranty shall not apply to any statements or omissions made in reliance
upon and in conformity with information furnished in writing to the Company by
an Underwriter through Goldman, Sachs & Co. expressly for use therein;

 3
 

 

(f)          Neither
the Company nor any of its subsidiaries has sustained since the date of the
latest audited financial statements included or incorporated by reference in
the Pricing Prospectus any material loss or interference with its business from
fire, explosion, flood or other calamity, whether or not covered by insurance,
or from any labor dispute or court or governmental action, order or decree,
otherwise than as set forth or contemplated in the Pricing Prospectus; and,
since the respective dates as of which information is given in the Registration
Statement and the Pricing Prospectus, there has not been any change in the
capital stock except for changes or adjustments made in the ordinary course of
business pursuant to
employee equity plans in existence on the date of this Agreement, or long term debt of the Company or any
of its subsidiaries other than the exercise of options outstanding on the date
of this Agreement or any material adverse change, or any development involving
a prospective material adverse change, in or affecting the general affairs,
management, financial position, stockholders’ equity or results of operations
of the Company and its subsidiaries taken as a whole, otherwise than as set
forth or contemplated in the Pricing Prospectus;

(g)         The
Company and its subsidiaries have good and marketable title in fee simple to
all real property and good and marketable title to all personal property owned
by them, in each case free and clear of all liens, encumbrances and defects
except such as are described in the Pricing Prospectus or such as do not
materially affect the value of such property and do not interfere with the use
made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the
Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not
interfere with the use made and proposed to be made of such property and
buildings by the Company and its subsidiaries;

(h)         The
Company has been duly incorporated and is validly existing as a corporation in
good standing under the laws of the State of Delaware, with power and authority
(corporate and other) to own its properties and conduct its business as
described in the Pricing Prospectus, and has been duly qualified as a foreign
corporation for the transaction of business and is in good standing under the
laws of each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification, or is subject to no
material liability or disability by reason of the failure to be so qualified in
any such jurisdiction; and each subsidiary of the Company has been duly
incorporated and is validly existing as a corporation in good standing under
the laws of its jurisdiction of incorporation;

(i)          The
Company has an authorized capitalization as set forth in the Pricing Prospectus
and all of the issued shares of capital stock of the Company have been duly and
validly authorized and issued and are fully paid and non-assessable and conform
to the description of the Stock contained in the Pricing Prospectus and
Prospectus; and all of the issued shares of capital stock of each subsidiary of
the Company have been duly and validly authorized and issued, are fully paid
and non-

 4
 

 

assessable and (except for directors’ qualifying
shares and as otherwise set forth in the Pricing Prospectus) are owned directly
or indirectly by the Company, free and clear of all liens, encumbrances,
equities or claims;

(j)          The
issue and sale of the Shares and the compliance by the Company with this
Agreement and the consummation of the transactions herein contemplated will not
conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which the Company or
any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company
or any of its subsidiaries is subject, nor will such action result in any
violation of the provisions of the Amended and Restated Certificate of
Incorporation or By-laws of the Company or any statute or any order, rule or
regulation of any court or governmental agency or body having jurisdiction over
the Company or any of its subsidiaries or any of their properties; and no
consent, approval, authorization, order, registration or qualification of or
with any such court or governmental agency or body is required for the issue
and sale of the Shares or the consummation by the Company of the transactions
contemplated by this Agreement except such as have been obtained under the Act
and such consents, approvals, authorizations, registrations or qualifications
as may be required under state securities or Blue Sky laws in connection with
the purchase and distribution of the Shares by the Underwriters;

(k)         Other
than as set forth in the Pricing Prospectus, there are no legal or governmental
proceedings pending to which the Company or any of its subsidiaries is a party
or of which any property of the Company or any of its subsidiaries is the
subject, which, if determined adversely to the Company or any of its
subsidiaries, would individually or in the aggregate have a material adverse
effect on the current or future financial position, stockholders’ equity or
results of operations of the Company and its subsidiaries taken as a whole;
and, to the best of the Company’s knowledge, no such proceedings are threatened
or contemplated by governmental authorities or threatened by others;

(l)          Neither
the Company nor any of its subsidiaries is in violation of its Certificate of
Incorporation or By-laws or in default in the performance or observance of any
material obligation, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement, lease or other agreement or instrument
to which it is a party or by which it or any of its properties may be bound;

(m)        The
statements set forth in the Pricing Prospectus and Prospectus under the caption
“Description of Capital Stock”, insofar as they purport to constitute a summary
of the terms of the Stock, and under the
caption “Underwriting”, insofar as they purport to describe the provisions of
the documents referred to therein, are accurate, complete and fair;

 5
 

 

(n)         The
Company is not and, after giving effect to the offering and sale of the Shares,
will not be an “investment company”, as such term is defined in the United
States Investment Company Act of 1940, as amended (the “Investment Company Act”);

(o)         (i)
At the time of filing the Registration Statement, (ii) at the time of the most
recent amendment thereto for the purposes of complying with Section 10(a)(3) of
the Act (whether such amendment was by post-effective amendment, incorporated
report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of
prospectus), and (iii) at the time the Company or any person acting on its
behalf (within the meaning, for this clause only, of Rule 163(c) under the Act)
made any offer relating to the Shares in reliance on the exemption of Rule 163
under the Act, the Company was a “well-known seasoned issuer” as defined in
Rule 405 under the Act; and (B) at the earliest time after the filing of the
Initial Registration Statement that the Company or another offering participant
made a bona fide offer (within the meaning of
Rule 164(h)(2) under the Act) of the Shares, the Company was not an “ineligible
issuer” as defined in Rule 405 under the Act;

(p)         Deloitte & Touche LLP, who have certified
certain financial statements of the Company and its subsidiaries, and have
audited the Company’s internal control over financial reporting and management’s
assessment thereof are an independent registered public accounting firm as
required by the Act and the rules and regulations of the Commission thereunder;

(q)         The
Company maintains a system of internal control over financial reporting (as
such term is defined in Rule 13a-15(f) under the Exchange Act) that complies
with the requirements of the Exchange Act and has been designed by the Company’s
principal executive officer and principal financial officer, or under their
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. The
Company’s internal control over financial reporting was effective as of a
December 31, 2005 evaluation thereof. 
The Company is not aware of any material weaknesses in its internal
control over financial reporting;

(r)    Other than as set forth in the Pricing
Prospectus, since the date of the latest audited financial statements included
or incorporated by reference in the Prospectus, there has been no change in the
Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting;

(s)       The Company maintains
disclosure controls and procedures (as such term is defined in Rule 13a-15(e)
under the Exchange Act) that comply with the requirements of the Exchange Act;
such disclosure controls and procedures have been designed to ensure that
material information relating to the Company and its subsidiaries is made known
to the Company’s principal executive
officer and principal

 6
 

 

financial officer by others within those entities;
and such disclosure controls and procedures are
effective;

(t)        The
Company has been subject to the requirements of Section 12 or 15(d) of the
Exchange Act and has filed all the material required to be filed pursuant to
Section 13, 14 or 15(d) for a period of at least 36 months immediately
preceding the filing of the Registration Statement and has filed in a timely
manner all reports required to be filed during the 12 calendar months and any
portion of a month immediately preceding the filing of the Registration
Statement); and

(u)  Neither
the Company nor any of its consolidated or unconsolidated subsidiaries have,
since December 31, 2005: (i) failed  to
pay any dividend or sinking fund installment on preferred stock; or (ii)
defaulted on either any installment or installments on indebtedness for
borrowed money or on any rental on one or more long term leases, which defaults
in the aggregate are material to the financial position of the Company and its
consolidated and unconsolidated subsidiaries, taken as a whole.

2.       Each of the Selling Stockholders severally represents and
warrants to, and agrees with each of the Underwriters and the Company that:

(i)          All
consents, approvals, authorizations and orders necessary for the execution and
delivery by such Selling Stockholder of this Agreement, and for the sale and
delivery of the Shares to be sold by such Selling Stockholder hereunder, have
been obtained; and such Selling Stockholder has full right, power and authority
to enter into this Agreement and to sell, assign, transfer and deliver the
Shares to be sold by such Selling Stockholder hereunder;

(ii)         The
sale of the Shares to be sold by such Selling Stockholder hereunder and the
compliance by such Selling Stockholder with all of the provisions of this
Agreement and the consummation of the transactions herein and therein
contemplated will not conflict with or result in a breach or violation of any
of the terms or provisions of, or constitute a default under, any statute,
indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which such Selling Stockholder is a party or by which such
Selling Stockholder is bound or to which any of the property or assets of such
Selling Stockholder is subject, nor will such action result in any violation of
the provisions of the Certificate of Incorporation or By-laws of such
Selling Stockholder if such Selling Stockholder is a corporation or any statute or any order, rule or regulation of any
court or governmental agency or body having jurisdiction over such Selling
Stockholder or the property of such Selling Stockholder;

(iii)        Such
Selling Stockholder has, and immediately prior to the Time of Delivery (as
defined in Section 5 hereof) such Selling Stockholder will have, good and
marketable title to the Shares to be sold by such Selling Stockholder
hereunder, free of all liens, encumbrances, equities or claims; and, upon
delivery of such Shares and payment therefor pursuant hereto, good and
marketable title to such Shares, free of all liens, encumbrances, equities or
claims, will pass to the several Underwriters;

 

 7

 

(iv)        [Reserved.]

(v)         Such
Selling Stockholder has not taken and will not take, directly or indirectly,
any action which is designed to or which has constituted or which might
reasonably be expected to cause or result in stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of
the Shares;

(vi)        All
information in respect of such Selling Stockholder or provided in writing by
such Selling Stockholder for inclusion in the Registration Statement, the Basic
Prospectus, any Preliminary Prospectus, the Pricing Prospectus, the Prospectus
or any amendment or supplement thereto, or any Issuer Free Writing Prospectus
does not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein not misleading; and

(vii)       In
order to document the Underwriters’ compliance with the reporting and
withholding provisions of the Tax Equity and Fiscal Responsibility Act of 1982
with respect to the transactions herein contemplated, such Selling Stockholder
had previously delivered to you on September 5, 2006 a properly completed and
executed United States Treasury Department Form W-8BEN, and, as of the
Time of Delivery (as hereinafter defined), such form will be accurate and complete
in all material respects.

3.         Subject to the terms and conditions
herein set forth, each of the Selling Stockholders agrees, severally and not
jointly, to sell to each of the Underwriters, and each of the Underwriters
agrees, severally and not jointly, to purchase from each of the Selling
Stockholders, at a purchase price per share of $39.00, the number of Shares (to
be adjusted by you so as to eliminate fractional shares) determined by
multiplying the aggregate number of Shares to be sold by each of the Selling
Stockholders as set forth opposite their respective names in Schedule II hereto
by a fraction, the numerator of which is the aggregate number of Shares to be
purchased by such Underwriter as set forth opposite the name of such
Underwriter in Schedule I hereto and the denominator of which is the aggregate
number of Shares to be purchased by all of the Underwriters from all of the
Selling Stockholders hereunder.

4.         Upon release of the Shares, the
Underwriters propose to offer the Shares for sale upon the terms and conditions
set forth in the Prospectus.

5.         (a)               The
Shares to be purchased by each Underwriter hereunder, in definitive form, and
in such authorized denominations and registered in such names as Goldman, Sachs
& Co. may request upon at least forty-eight hours’ prior notice to the Selling Stockholders shall be delivered by or on behalf
of the Selling Stockholders to Goldman, Sachs & Co., through the facilities
of the Depository Trust Company (“DTC”), for the account of such Underwriter,
against payment by or on behalf of such Underwriter of the purchase price
therefor by wire transfer of Federal (same-day) funds to the account specified
by each of the Selling Stockholders to Goldman, Sachs & Co. at least forty-eight
hours in advance.  The Company will cause
the certificates representing the Shares to be made available for checking and
packaging at least twenty-four hours prior to the Time of Delivery (as defined 

 8
 

 

below) at the office of Goldman, Sachs &
Co., 85 Broad Street, New York, New York 10004 (the “Designated Office”).  The time and date of such delivery and
payment shall be 9:30 a.m., New York City time, on December 7, 2006 or such
other time and date as Goldman, Sachs & Co. and the Selling Stockholders
may agree upon in writing.  Such time and
date are herein called the “Time of Delivery”.

 (b)      The
documents to be delivered at the Time of Delivery by or on behalf of the
parties hereto pursuant to Section 9 hereof, including the cross receipt for
the Shares and any additional documents requested by the Underwriters pursuant
to Section 9 (j) hereof, will be delivered at the offices of Latham &
Watkins LLP, 885 Third Avenue, New York, New York 10022 (the “Closing Location”),
and the Shares will be delivered at the Designated Office, all at the Time of
Delivery.  A meeting will be held at the
Closing Location at 5:00 p.m., New York City time, on the New York
Business Day next preceding the Time of Delivery, at which meeting the final
drafts of the documents to be delivered pursuant to the preceding sentence will
be available for review by the parties hereto. 
For the purposes of this Section 5, “New York Business Day” shall mean
each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on
which banking institutions in New York are generally authorized or obligated by
law or executive order to close.

6.         The
Company agrees with each of the Underwriters:

(a)         To prepare the Prospectus in a form
approved by you and to file such Prospectus pursuant to Rule 424(b) under the
Act not later than the Commission’s close of business on the second business
day following the date of this Agreement or such earlier time as may be
required under the Act; to make no further amendment or any supplement to the
Registration Statement, the Basic Prospectus or the Prospectus prior to the
Time of Delivery which shall be disapproved by you promptly after reasonable
notice thereof; to advise you, promptly after it receives notice thereof, of
the time when any amendment to the Registration Statement has been filed or
becomes effective or any amendment or supplement to the Prospectus has been
filed and to furnish you with copies thereof; to file promptly all material
required to be filed by the Company with the Commission pursuant to Rule 433(d)
under the Act; within the time required by such Rule; to file promptly all
reports and any definitive proxy or information statements required to be filed
by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or
15(d) of the Exchange Act subsequent to the date of the Prospectus and for so
long as the delivery of a prospectus (or in lieu thereof, the notice referred
to in Rule 173(a) under the Act) is required in connection with the offering or
sale of the Shares; to advise you, promptly after it receives notice thereof,
of the issuance by the Commission of any stop order or of any order preventing
or suspending the use of any Preliminary Prospectus or other prospectus in
respect of the Shares, of any notice of objection of the Commission to the use
of the Registration Statement or any post-effective amendment thereto pursuant
to Rule 401(g)(2) under the Act of the suspension of the qualification of the
Shares for offering or sale in any jurisdiction, of the initiation or threatening
of any proceeding for any such purpose, or of any request by the Commission for
the amending or supplementing of 

 9
 

 

the
Registration Statement or the Prospectus or for additional information; and, in
the event of the issuance of any stop order or of any order preventing or
suspending the use of any Preliminary Prospectus or other prospectus or
suspending any such qualification, to promptly use its best efforts to obtain
the withdrawal of such order; and in the event of any such issuance of a notice
of objection, promptly to take such steps, including, without limitation,
amending the Registration Statement or filing a new registration statement, at
its own expense, as may be necessary to permit offers and sales of the Shares
by the Underwriters (references herein to the Registration Statement shall
include any such amendment or new registration statement);

(b)         If required by Rule 430B(h) under the
Act, to prepare a form of prospectus in a form approved by you and to file such
form of prospectus pursuant to Rule 424(b) under the Act not later than may be
required by Rule 424(b) under the Act; and to make no further amendment or
supplement to such form of prospectus which shall be disapproved by you
promptly after reasonable notice therereof;

(c)         If by the third anniversary (the “Renewal
Deadline”) of the initial effective date of the Registration Statement, any of
the Shares remain unsold by the Underwriters, the Company will file, if it has
not already done so and is eligible to do so, a new automatic shelf
registration statement relating to the Shares, in a form satisfactory to
you.  If at the Renewal Deadline the
Company is no longer eligible to file an automatic shelf registration
statement, the Company will, if it has not already done so, file a new shelf
registration statement relating to the Shares, in a form satisfactory to you
and will use its best efforts to cause such registration statement to be
declared effective within 180 days after the Renewal Deadline.  The Company will take all other action
necessary or appropriate to permit the public offering and sale of the Shares
to continue as contemplated in the expired registration statement relating to
the Shares.  References herein to the
Registration Statement shall include such new automatic shelf registration
statement or such new shelf registration statement, as the case may be;

(d)         Promptly
from time to time to take such action as you may reasonably request to qualify
the Shares for offering and sale under the securities laws of such jurisdictions
as you may request and to comply with such laws so as to permit the continuance
of sales and dealings therein in such jurisdictions for as long as may be
necessary to complete the distribution of the Shares, provided that in
connection therewith the Company shall not be required to qualify as a foreign
corporation or to file a general consent to service of process in any
jurisdiction;

(e)         Prior
to 10:00 a.m., New York City time, on the New York Business Day next succeeding
the date of this Agreement and from time to time, to furnish the Underwriters
with written and electronic copies of the Prospectus in New York City in such
quantities as you may reasonably request, and, if the delivery of a prospectus
(or in lieu thereof, the notice referred to in Rule 173(a) under the Act) is
required at any time prior to the expiration of nine months after the time of
issue of the Prospectus in connection with the offering or sale of the Shares
and if at such time any event shall 

 10
 

 

have occurred as a result of which the
Prospectus as then amended or supplemented would include an untrue statement of
a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were
made when such Prospectus (or in lieu thereof, the notice referred to in Rule
173(a) under the Act) is delivered, not misleading, or, if for any other reason
it shall be necessary or desirable during such same period to amend or
supplement the Prospectus or to file under the Exchange Act any document
incorporated by reference in the Prospectus in order to comply with the Act or
the Exchange Act, to notify you and upon your request to file such document and
to prepare and furnish without charge to each Underwriter and to any dealer in
securities as many written and electronic copies as you may from time to time
reasonably request of an amended Prospectus or a supplement to the Prospectus
which will correct such statement or omission or effect such compliance; and in
case any Underwriter is required to deliver a prospectus (or in lieu thereof,
the notice referred to in Rule 173(a) under the Act) in connection with sales
of any of the Shares at any time nine months or more after the time of issue of
the Prospectus, upon your request but at the expense of such Underwriter, to
prepare and deliver to such Underwriter as many written and electronic copies
as you may request of an amended or supplemented Prospectus complying with
Section 10(a)(3) of the Act;

(f)          To
make generally available to its security holders as soon as practicable, but in
any event not later than sixteen months after the effective date of the
Registration Statement (as defined in Rule 158(c) under the Act), an earnings
statement of the Company and its subsidiaries (which need not be audited)
complying with Section 11(a) of the Act and the rules and regulations of the
Commission thereunder (including, at the option of the Company, Rule 158);

(g)         [Reserved.]

(h)         To
pay the required Commission filing fees relating to the Shares within the time
required by Rule 456(b)(1) under the Act without regard to the proviso
therein and otherwise in accordance with Rules 456(b) and 457(r) under the
Act;

(i)          Upon
request of any Underwriter, to furnish, or cause to be furnished, to such
Underwriter an electronic version of the Company’s trademarks, servicemarks and
corporate logo for use on the website, if any, operated by such Underwriter for
the purpose of facilitating the on-line offering of the Shares (the “License”);
provided, however, that the License shall be used solely for the purpose
described above, is granted without any fee and may not be assigned or
transferred; and

(j)          The
Shares at the Time of Delivery shall have been duly listed, subject to notice
of issuance on the Nasdaq National Market.

7.             (a)           The Company and each Selling
Stockholder represents and agrees that, without the prior consent of Goldman,
Sachs & Co., it has not made and will not make any offer relating to the
Shares that would constitute a “free writing prospectus” as defined in Rule 405
under the Act; each Underwriter represents and agrees that, without the prior
consent of 

 11
 

 

the
Company and Goldman, Sachs & Co., it has not made and will not make any
offer relating to the Shares that would constitute a free writing prospectus;
any such free writing prospectus the use of which has been consented to by the
Company and Goldman, Sachs & Co. is listed on Schedule III(a) hereto;

(b)           The Company has
complied and will comply with the requirements of Rule 433 under the Act
applicable to any Issuer Free Writing Prospectus, including timely filing with
the Commission or retention where required and legending; and

(c)
          The Company agrees that if at
any time following issuance of an Issuer Free Writing Prospectus any event
occurred or occurs as a result of which such Issuer Free Writing Prospectus
would conflict with the information in the Registration Statement, the Pricing
Prospectus or the Prospectus or would include an untrue statement of a material
fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances then prevailing, not
misleading, the Company will give prompt notice thereof to Goldman, Sachs &
Co. and, if requested by Goldman, Sachs & Co., will prepare and furnish
without charge to each Underwriter an Issuer Free Writing Prospectus or other
document which will correct such conflict, statement or omission; provided,
however, that this representation and warranty shall not apply to any statements
or omissions in an Issuer Free Writing Prospectus made in reliance upon and in
conformity with information furnished in writing to the Company by an
Underwriter through Goldman, Sachs & Co. expressly for use therein.

8.         The Company and each of the Selling
Stockholders covenant and agree with one another and with the several
Underwriters that the Company will pay or cause to be paid the following: (i)
the fees, disbursements and expenses of the Company’s counsel and accountants
in connection with the registration of the Shares under the Act and all other
expenses in connection with the preparation, printing and filing of the
Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the
Pricing Prospectus and the Prospectus and amendments and supplements thereto
and any Issuer Free Writing Prospectus and the mailing and delivering of copies
thereof to the Underwriters and dealers; (ii) the cost of printing or producing
any Agreement among Underwriters, this Agreement, the Blue Sky Memorandum,
closing documents (including any compilations thereof) and any other documents
in connection with the offering, purchase, sale and delivery of the Shares;
(iii) all expenses in connection with the qualification of the Shares for
offering and sale under state securities laws as provided in Section 6(b)
hereof, including the fees and disbursements of counsel for the Underwriters in
connection with such qualification and in connection with the Blue Sky survey;
(iv) the filing fees incident to, and the reasonable fees and disbursement of
counsel for the Underwriters in connection with, securing any required review
by the National Association of Securities Dealers, Inc. of the terms of the
sale of the Shares; (v) the cost of preparing stock certificates; (vi) the cost
and charges of any transfer agent or registrar and (vii) all other costs and
expenses incident to the performance of its obligations hereunder which are not
otherwise specifically provided for in this Section.  It is understood, however, that, except as
provided in this Section, and Sections 10 and 13 hereof, the Underwriters will 

 12
 

 

pay all of their own costs and expenses,
including the fees of their counsel, stock transfer taxes on resale of any of
the Shares by them, and any advertising expenses connected with any offers they
may make.

9.         The obligations of the Underwriters
hereunder shall be subject, in their discretion, to the condition that all
representations and warranties and other statements of the Company and of the
Selling Stockholders herein are, at and as of the Time of Delivery, true and
correct, the condition that the Company and the Selling Stockholders shall have
performed all of its and their obligations hereunder theretofore to be
performed, and the following additional conditions:

(a)         The
Prospectus shall have been filed with the Commission pursuant to Rule 424(b)
under the Act within the applicable time period prescribed for such filing by
the rules and regulations under the Act and in accordance with Section 5(a)
hereof; all material required to be filed by the Company pursuant to Rule
433(d) under the Act shall have been filed with the Commission within the
applicable time period prescribed for such filings by Rule 433; no stop order
suspending the effectiveness of the Registration Statement or any part thereof
shall have been issued and no proceeding for that purpose shall have been
initiated or threatened by the Commission and no notice of objection of the
Commission to the use of the Registration Statement or any post-effective
amendment thereto pursuant to Rule 401(g)(2) under the Act shall have been
received; no stop order suspending or preventing the use of the Prospectus or
any Issuer Free Writing Prospectus shall have been initiated or threatened by
the Commission; and all requests for additional information on the part of the
Commission shall have been complied with to your reasonable satisfaction;

(b)         Latham
& Watkins LLP, counsel for the Underwriters, shall have furnished to you
such written opinion or opinions and letter, dated the Time
of Delivery, with respect to matters as you may reasonably request, and such
counsel shall have received such papers and information as they may reasonably
request to enable them to pass upon such matters;

(c)         Peter
J. Millones, Executive Vice President and General Counsel for the Company,
shall have furnished to you his written opinion on behalf of the Company, dated
the Time of Delivery, in form and substance satisfactory to you, to the effect
that:

(i)          The
Company has power and authority (corporate and other) to own its properties and
conduct its business as described in the Prospectus;

(ii)         The
Company, as of the closing date, has an authorized capitalization as set forth
in the Prospectus, and all of the issued shares of capital stock of the Company
(including the Shares) have been duly and validly authorized and issued and are
fully paid and non-assessable and the Shares conform to the description of the
Shares in the Prospectus;

(iii)        The
Company has been duly qualified as a foreign corporation for the transaction of
business and is in good standing under the laws of each other 

 13
 

 

jurisdiction in which it owns or leases
properties or conducts any business so as to require such qualification, or is
subject to no material liability or disability by reason of the failure to be
so qualified in any such jurisdiction (such counsel being entitled to rely in
respect of the opinion in this clause upon opinions of local counsel and in
respect of matters of fact upon certificates of officers of the Company,
provided that such counsel shall state that they believe that both you and they
are justified in relying upon such opinions and certificates);

(iv)        Each
subsidiary of the Company listed on Schedule IV hereto (each “subsidiary”) has
been duly incorporated and is validly existing as a corporation in good
standing under the laws of its jurisdiction of incorporation; and all of the
issued shares of capital stock of each such subsidiary have been duly and
validly authorized and issued, are fully paid and non-assessable, and
(except for directors’ qualifying shares and as otherwise set forth in the
Pricing Prospectus) are owned directly or indirectly by the Company, free and
clear of all liens, encumbrances, equities or claims (such counsel being
entitled to rely in respect of the opinion in this clause upon opinions of
local counsel and in respect of matters of fact upon certificates of officers
of the Company or its subsidiaries, provided that such counsel shall state that
they believe that both you and they are justified in relying upon such opinions
and certificates);

(v)         To
the best of such counsel’s knowledge and other than as set forth in the
Prospectus, there are no legal or governmental proceedings pending to which the
Company or any of its subsidiaries is a party or of which any property of the
Company or any of its subsidiaries is the subject which, if determined
adversely to the Company or any of its subsidiaries, would individually or in
the aggregate have a material adverse effect on the current or future
consolidated financial position, stockholders’ equity or results of operations
of the Company and its subsidiaries; and to the best of such counsel’s
knowledge, no such proceedings are threatened or contemplated by governmental
authorities or threatened by others;

(vi)        The
issue and sale of the Shares and the compliance by the Company with this
Agreement and the consummation of the transactions herein contemplated will not
conflict with or result in a breach or violation of any of the terms or provisions
of, or constitute a default under, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument known to such counsel to which the
Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries is bound or to which any of the property or assets of the
Company or any of its subsidiaries is subject, nor will such actions result in
any violation of the provisions of the Certificate of Incorporation or By-laws
of the Company or any statute or any order, rule or regulation known to such
counsel of any court or governmental agency or body having jurisdiction over
the Company or any of its subsidiaries or any of their properties;

 14
 

 

(vii)       No
consent, approval, authorization, order, registration or qualification of or
with any such court or governmental agency or body is required for the issue
and sale of the Shares or the consummation by the Company of the transactions
contemplated by this Agreement, except such as have been obtained under the Act
and such consents, approvals, authorizations, registrations or qualifications
as may be required under state securities or Blue Sky laws in connection with
the purchase and distribution of the Shares by the Underwriter;

(viii)      Neither
the Company nor any of its subsidiaries is in violation of its Certificate of
Incorporation or By-laws or in default in the performance or observance of any
obligation, agreement, covenant or condition contained in any indenture,
mortgage, deed of trust, loan agreement, lease or other agreement or instrument
to which it is a party or by which it or any of its properties may be bound,
except for such defaults which would not individually or in the aggregate have
a material adverse affect on the current or future consolidated financial
position, stockholders’ equity or results of operations of the Company and its
subsidiaries taken as a whole;

(ix)        The
documents incorporated by reference in the Prospectus or any further amendment
or supplement thereto, made by the Company prior to such Time of Delivery
(other than the financial statements and related schedules therein, as to which
such counsel need express no opinion), when they became effective or were filed
with the Commission, as the case may be, complied as to form in all material
respects with the requirements of the Act or the Exchange Act, as applicable,
and the rules and regulations of the Commission thereunder; and they have no
reason to believe that any of such documents, when they became effective or
were so filed, as the case may be, contained, in the case of a registration
statement which became effective under the Act, an untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary to make the statements therein not misleading; and

(x)         The
Company does not know of any amendment to the Registration Statement required
to be filed or of any contracts or other documents of a character required to
be filed as an exhibit to the Registration Statement or required to be incorporated
by reference into the Prospectus or required to be described in the
Registration Statement, the Basic Prospectus or the Prospectus which are not
filed or incorporated by reference or described as required.

(d)         Sullivan
& Cromwell LLP, counsel for the Company, shall have furnished to you their
written opinion (a draft of such opinion is attached as Annex II(a) hereto),
dated the Time of Delivery, in form and substance satisfactory to you, to the
effect that:

 15
 

 

(i)          The
Company has been duly incorporated and is an existing corporation in good
standing under the laws of the jurisdiction of its incorporation;

(ii)         This
Agreement has been duly authorized, executed and delivered by the Company;

(iii)        The
Company is not and, after giving effect to the offering and sale of the Shares,
will not be an “investment company”, as such term is defined in the Investment
Company Act; and

(iv)        The
Registration Statement, the Prospectus and any further amendments and
supplements thereto, as applicable, made by the Company prior to the Time of Delivery (other than the financial statements and
related schedules therein, as to which such counsel need express no opinion)
appeared on their face to be responsive in all material respects, with the
requirements of the Act and the rules and regulations thereunder; although they
do not assume any responsibility for the accuracy, completeness or fairness of
the statements contained in the Registration Statement, the Pricing Prospectus
or the Prospectus, except for those made under the caption “Description of
Capital Stock” in the Prospectus insofar as they purport to constitute a
summary of the terms of the Shares and under the caption “Underwriting” insofar
as they purport to describe the provisions of the underwriting agreement referred
to therein, nothing has come to their attention to cause them to believe (i)
that any part of the Registration Statement, or any further amendment thereto
made by the Company prior to the Time of
Delivery (other than the financial statements and related schedules therein, as
to which such counsel need express no opinion), when such part or amendment
became effective, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary to make the
statements therein not misleading; (ii) that the Pricing Prospectus when
considered together with the public offering price, as of the Applicable Time, contained any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading; or (iii) that, as of its date and as of the Time
of Delivery, the Prospectus or any further amendment or supplement thereto made
by the Company prior to the Time of
Delivery (other than the financial statements and related schedules therein, as
to which such counsel need express no opinion) contained or contains any untrue
statement of a material fact or omitted or omits to state a material fact
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading.

(e)         Shearman
& Sterling LLP, counsel for the Selling Stockholders, as indicated in
Schedule II hereto, shall have furnished to you their written opinion with
respect to the Selling Stockholders for whom they are acting as counsel (a
draft of 

 16
 

 

each such opinion is attached as Annex II(b)
hereto), dated the Time of
Delivery, in form and substance satisfactory to you, to the effect that:

(i)          This
Agreement has been duly executed and delivered by or on behalf of such Selling
Stockholder;

(ii)         No
consent, approval, authorization, order, registration or qualification of any
United States federal or New York state governmental authority or regulatory
body is required for the consummation of the transactions contemplated by this
Agreement in connection with the Shares to be sold by such Selling Stockholder
hereunder, except for such consents, approvals, authorizations, orders,
registrations or qualifications as have been obtained under the Act and such as
may be required under state securities or Blue Sky laws in connection with the
purchase and distribution of such Shares by the Underwriters; and

(iii)        Upon (1) physical
delivery of the certificates evidencing the Shares listed on Schedule II hereto
to the transfer agent for the Company in exchange for uncertificated shares of
stock, (2) registration by book entry in the stock records of the Company of
the Shares in the name of CEDE & Co., for further credit to the
Representative at its securities account maintained through DTC, (3) indication
by book entry by DTC that the Shares have been credited to a securities account
maintained by the Representative at DTC, and (4) payment for the Shares in accordance
with the terms of the Underwriting Agreement, the Underwriters will acquire
securities entitlements with respect to such Shares and, under the New York
Uniform Commercial Code (“NY UCC”), an action based on an adverse claim to such
securities entitlement, whether framed in conversion, replevin, constructive
trust, equitable lien or other theory, may not be asserted against the
Underwriters (assuming that the Underwriters are without notice of the adverse
claim).

(f)          Maples and Calder,
special British Virgin Islands counsel for the Selling Stockholders, as
indicated in Schedule II hereto, shall have furnished to you their written
opinions with respect to each of the Selling Stockholders for whom they are
acting as special British Virgin Islands counsel (a draft of each such opinion
is attached as Annex II(c) hereto), dated the Time
of Delivery, in form and substance satisfactory to you, to the effect that:

(i)              Such
Selling Stockholder is a limited liability company duly incorporated under the
British Virgin Islands International Business Companies Act, 1984 (as amended),
in good standing at the Registry of Corporate Affairs and validly existing
under the laws of the British Virgin Islands, and possesses the capacity to sue
and be sued in its own name;

 17

 

(ii)           Such
Selling Stockholder has full power and authority under its Memorandum and
Articles of Association and the laws of the British Virgin Islands to enter
into, execute, deliver and perform its obligations under this Agreement and to
sell, transfer and deliver the Shares to the Underwriters free and clear of all
liens, restrictions on transfers, encumbrances, security interests and claims
whatsoever as contemplated by this Agreement;

(iii)          The
execution and delivery of this Agreement and the performance by such Selling
Stockholder of its obligations hereunder does not conflict with or result in a
breach of any of the terms or provisions of the memorandum and articles of
association of such Selling Stockholder or any law, public rule or regulation
applicable to such Selling Stockholder in the British Virgin Islands currently
in force and does not conflict with or result in a breach or constitute a
default under any existing rule, regulation, order or decree of any
governmental authority or agency or official body of the British Virgin
Islands;

(iv)          The
execution, delivery and performance of this Agreement has been authorised by
and on behalf of such Selling Stockholder;

(v)           The
execution, delivery and performance of this Agreement has been authorised by and
on behalf of such Selling Stockholder and, assuming this Agreement has been
executed and delivered by an authorized person, this Agreement has been duly
executed and delivered on behalf of such Selling Stockholder and constitute the
legal, valid and binding obligations of such Selling Stockholder enforceable in
accordance with their terms;

(vi)          No
authorisations, consents, approvals, licences, validations or exemptions are
required by law from any governmental authorities or agencies or other official
bodies in the British Virgin Islands in connection with: (1) the creation,
execution or delivery of this Agreement by such Selling Stockholder; (2)
subject to the payment of the appropriate nominal stamp duty, enforcement of
this Agreement against such Selling Stockholder; or (3) the performance by such
Selling Stockholder of its obligations under this Agreement;

(vii)         No
taxes, fees or charges (other than nominal stamp duty) are payable (either by
direct assessment or withholding) to the government or other taxing authority
in the British Virgin Islands under the laws of the British Virgin Islands in
respect of (1) the execution or delivery of this Agreement; (2) the enforcement
of this Agreement; (3) the performance of this Agreement; and; (4) payments
made under, or pursuant to, this Agreement;

(viii)        The
British Virgin Islands currently have no form of income, corporate or capital
gains tax and no estate duty, inheritance tax or gift tax;

 18
 

 

 (ix)          The courts of the British Virgin
Islands will observe and give effect to the choice of New York law as the
governing law of this Agreement;

(x)            Any
final and conclusive monetary judgment obtained against such Selling
Stockholder in the courts of New York in respect of this Agreement, for a
definite sum, may be treated by the courts of the British Virgin Islands as a
cause of action in itself so that no retrial of the issues would be necessary
provided that in respect of the foreign judgment: (1) the foreign court issuing
the judgment had jurisdiction in the matter and such Selling Stockholder either
submitted to such jurisdiction or was resident or carrying on business within
such jurisdiction and was duly served with process; (2) the judgment given by
the foreign court was not in respect of penalties, taxes, fines or similar
fiscal or revenue obligations of such Selling Stockholder; (3) in obtaining
judgment there was no fraud on the part of the person in whose favour judgment
was given or on the part of the court; (4) recognition or enforcement of the
judgment in the British Virgin Islands would not be contrary to public policy;
and (5) the proceedings pursuant to which judgment was obtained were not
contrary to natural justice;

(xi)           It
is not necessary to ensure the legality, validity, enforceability or
admissibility in evidence of this Agreement that any document be filed,
recorded or enrolled with any governmental authority or agency or any official
body in the British Virgin Islands;

(xii)          Our
search at the Registry of Corporate Affairs did not reveal the existence of a
Register of Mortgages, Charges and Other Encumbrances.  A Register of Mortgages, Charges and Other
Encumbrances may, however, be maintained at such Selling Stockholder’s
registered office without a copy necessarily being filed at the Registry of
Corporate Affairs.  However, we refer you
to the registered agent’s certificate (a copy of which is attached as Annex A
to the opinion) that states that such Selling Stockholder does not maintain a
Register of Mortgages Charges and Other Encumbrances at such Selling
Stockholder’s registered office; and

(xiii)         Neither
such Selling Stockholder nor its assets is entitled to any immunity under the
laws of the British Virgin Islands, whether characterised as sovereign immunity
or otherwise, for any legal proceedings in the British Virgin Islands to
enforce or collect upon this Agreement.

(g)           On the date of the Prospectus at a
time prior to the execution of this Agreement, at 9:30 a.m., New York City
time, on the effective date of any post effective amendment to the Registration
Statement filed subsequent to the date of this Agreement and also at the Time
of Delivery, Deloitte & Touche LLP shall have furnished to you a letter or
letters, dated the respective dates of delivery thereof, in form and substance
satisfactory to you, to the effect set forth in Annex I hereto (the 

 19
 

 

executed copy of
the letter delivered prior to the execution of this Agreement is attached as
Annex I(a) hereto and a form of letter to be delivered on the effective date of
any post-effective amendment to the Registration Statement, and as of the Time
of Delivery is attached as Annex I(b) hereto);

(h)           (i) 
Neither the Company nor any of its subsidiaries shall have sustained
since the date of the latest audited financial statements included or incorporated
by reference in the Pricing Prospectus any loss or interference with its
business from fire, explosion, flood or other calamity, whether or not covered
by insurance, or from any labor dispute or court or governmental action, order
or decree, otherwise than as set forth or contemplated in the Pricing
Prospectus, and (ii) since the respective dates as of which information is
given in the Pricing Prospectus there shall not have been any change in the
capital stock except for changes or adjustments made in the ordinary course of
business pursuant to employee equity plans in
existence on the date of this Agreement or long-term debt
of the Company or any of its subsidiaries other than the exercise of options
outstanding on the date of this Agreement or any change, or any development
involving a prospective change, in or affecting the general affairs,
management, financial position, stockholders’ equity or results of operations
of the Company and its subsidiaries taken as a whole, otherwise than as set
forth or contemplated in the Pricing Prospectus, the effect of which, in any
such case described in clause (i) or (ii), is in your judgment so material and
adverse as to make it impracticable or inadvisable to proceed with the public
offering or the delivery of the Shares on the terms and in the manner
contemplated in the Prospectus;

(i)            On or after the Applicable Time (i)
no downgrading shall have occurred in the rating accorded the Company’s debt
securities or preferred stock by any “nationally recognized statistical rating
organization”, as that term is defined by the Commission for purposes of Rule
436(g)(2) under the Act, and (ii) no such organization shall have publicly
announced that it has under surveillance or review, with possible negative
implications, its rating of any of the Company’s debt securities or preferred
stock;

(j)            On or after the Applicable Time
there shall not have occurred any of the following: (i) a suspension or
material limitation in trading in securities generally on the Nasdaq National Market; (ii) a suspension or material limitation in trading in the
Company’s securities on the Nasdaq National Market; (iii) a general moratorium
on commercial banking activities declared by either Federal or New York State
authorities or a material disruption in commercial banking or securities
settlement or clearance services in the United States; (iv) the outbreak or
escalation of hostilities involving the United States or the declaration by the
United States of a national emergency or war or (v) the occurrence of any other
calamity or crisis or any change in financial, political or economic conditions
in the United States or elsewhere; if the effect of any such event specified in
clause (iv) or (v) in your judgment makes it impracticable or inadvisable to
proceed with the public offering or the delivery of the Shares being

 20
 

 

delivered at the Time of
Delivery on the terms and in the manner contemplated in the Prospectus;

(k)           The Company shall have complied with
the provisions of Section 6(c) hereof with respect to the furnishing of
prospectuses on the New York Business Day next succeeding the date of this
Agreement;

(l)            [Reserved.]

(m)          Each of the Selling Stockholders shall
have furnished to the Underwriter  wire
instructions for the transfer of the net proceeds of the offering to their
respective United States-based bank accounts;

(n)           [Reserved.]; and

(o)           The Company shall have furnished or
caused to be furnished to you at the Time of Delivery certificates of officers
of the Company satisfactory to you as to the accuracy of the representations
and warranties of the Company herein at and as of such Time of Delivery, as to
the performance by the Company of all of its obligations hereunder to be
performed at or prior to such Time of Delivery, as to the matters set forth in
subsections (a) and (e) of this Section and as to such other matters as you may
reasonably request.

10.           (a)  The Company will indemnify and hold harmless
each Underwriter against any losses, claims, damages or liabilities, joint or
several, to which such Underwriter may become subject, under the Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon an untrue statement or
alleged untrue statement of a material fact contained in the Registration
Statement, the Basic Prospectus, any Preliminary Prospectus, the Pricing
Prospectus or the Prospectus, or any amendment or supplement thereto, any
Issuer Free Writing Prospectus or any “issuer information” filed or required to
be filed pursuant to Rule 433(d) under the Act, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not
misleading, and will reimburse each Underwriter for any legal or other expenses
reasonably incurred by such Underwriter in connection with investigating or
defending any such action or claim as such expenses are incurred; provided,
however, that the Company shall not be liable in any such case to the extent
that any such loss, claim, damage or liability arises out of or is based upon
an untrue statement or alleged untrue statement or omission or alleged omission
made

 21
 

 

in the Registration Statement, the Basic Prospectus,
any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any
amendment or supplement thereto, or any Issuer Free Writing Prospectus, in
reliance upon and in conformity with written information furnished to the
Company by any Underwriter through Goldman, Sachs & Co. expressly for use
therein.

(b)           Each
of the Selling Stockholders, jointly and severally will indemnify and hold
harmless each Underwriter against any losses, claims, damages or liabilities,
joint or several, to which such Underwriter may become subject, under the Act
or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon an untrue statement
or alleged untrue statement or omission or alleged omission made in the
Registration Statement, the Basic Prospectus, any Preliminary Prospectus, the
Pricing Prospectus or the Prospectus, or any amendment or supplement thereto,
or any Issuer Free Writing Prospectus, or arise out of or are based upon the
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, and
will reimburse each Underwriter for any legal or other expenses reasonably
incurred by such Underwriter in connection with investigating or defending any
such action or claim as such expenses are incurred, in each case to the extent,
but only to the extent, that such untrue statement or alleged untrue statement
or omission or alleged omission was made in the Registration Statement, the Basic
Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the
Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing
Prospectus, in reliance upon and in conformity with written information
furnished to any Underwriter by any Selling Stockholder expressly for use
therein.

(c)           Each
Underwriter will indemnify and hold harmless the Company and each Selling
Stockholder against any losses, claims, damages or liabilities to which the
Company or such Selling Stockholder may become subject, under the Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon an untrue statement or
alleged untrue statement of a material fact contained in the Registration Statement,
the Basic Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the
Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing
Prospectus, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading, in each case to the extent, but
only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission was made in the Registration Statement, the Basic
Prospectus, any Preliminary Prospectus, the Pricing Prospectus or the
Prospectus, or any amendment or supplement thereto, or any Issuer Free Writing
Prospectus, in reliance upon and in conformity with written information
furnished to the Company by such Underwriter through Goldman, Sachs & Co.
expressly for use therein; and will reimburse the Company and each Selling
Stockholder for any legal or other expenses reasonably incurred by the Company
in connection with investigating or defending any such action or claim as such
expenses are incurred.

(d)           Promptly
after receipt by an indemnified party under subsection (a), (b) or (c) above of
notice of the commencement of any action, such indemnified party shall, if a
claim in respect thereof is to be made against the indemnifying party under
such subsection, notify the indemnifying party in writing of the commencement
thereof; but the omission so to notify the indemnifying party shall not relieve
it from any liability which it may have to any indemnified party otherwise than
under such subsection.  In case any such
action shall be brought against any indemnified party and it shall notify the
indemnifying party of the commencement thereof, the indemnifying party shall be
entitled to participate therein and, to the extent that it shall wish, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel satisfactory to such indemnified party (who shall not,
except with the consent of the indemnified party, be counsel to the
indemnifying party), and, after notice from the indemnifying party to such
indemnified party of its election so to

 22
 

 

assume the defense thereof, the indemnifying party
shall not be liable to such indemnified party under such subsection for any
legal expenses of other counsel or any other expenses, in each case
subsequently incurred by such indemnified party, in connection with the defense
thereof other than reasonable costs of investigation.  No indemnifying party shall, without the
written consent of the indemnified party, effect the settlement or compromise
of, or consent to the entry of any judgment with respect to, any pending or
threatened action or claim in respect of which indemnification or contribution
may be sought hereunder (whether or not the indemnified party is an actual or
potential party to such action or claim) unless such settlement, compromise or
judgment (i) includes an unconditional release of the indemnified party from
all liability arising out of such action or claim and (ii) does not include any
statement as to or an admission of fault, culpability or a failure to act, by
or on behalf of any indemnified party.

(e)           If
the indemnification provided for in this Section 10 is unavailable to or insufficient
to hold harmless an indemnified party under subsection (a), (b), (c) or (d)
above in respect of any losses, claims, damages or liabilities (or actions in
respect thereof) referred to therein, then each indemnifying party shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages or liabilities (or actions in respect thereof)
in such proportion as is appropriate to reflect the relative benefits received
by the Company on the one hand and the Underwriters on the other from the
offering of the Shares.  If, however, the
allocation provided by the immediately preceding sentence is not permitted by
applicable law or if the indemnified party failed to give the notice required
under subsection (d)  above, then each
indemnifying party shall contribute to such amount paid or payable by such
indemnified party in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company on the one hand
and the Underwriters on the other in connection with the statements or
omissions which resulted in such losses, claims, damages or liabilities (or
actions in respect thereof), as well as any other relevant equitable
considerations.  The relative benefits
received by the Company on the one hand and the Underwriters on the other shall
be deemed to be in the same proportion as the total net proceeds from the
offering (before deducting expenses) received by the Company bear to the total
underwriting discounts and commissions received by the Underwriters, in each
case as set forth in the table on the cover page of the Prospectus.  The relative fault shall be determined by
reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or
the Underwriters on the other and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission.  The Company and the
Underwriters agree that it would not be just and equitable if contribution
pursuant to this subsection (e) were determined by pro rata
allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation which does not take account of
the equitable considerations referred to above in this subsection (e).  The amount paid or payable by an indemnified
party as a result of the losses, claims, damages or liabilities (or actions in
respect thereof) referred to above in this subsection (e) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or

 23
 

 

defending any such action or claim.  Notwithstanding the provisions of this
subsection (e), no Underwriter shall be required to contribute any amount in
excess of the amount by which the total price at which the Shares underwritten
by it and distributed to the public were offered to the public exceeds the
amount of any damages which such Underwriter has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged
omission.  No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.  The Underwriters’
obligations in this subsection (e) to contribute are several in proportion to
their respective underwriting obligations and not joint.

(f)            The obligations of the Company and the Selling
Stockholders under this Section 10 shall be in addition to any liability which
the Company and the respective Selling Stockholders may otherwise have and
shall extend, upon the same terms and conditions, to each person, if any, who
controls any Underwriter within the meaning of the Act; and the obligations of
the Underwriters under this Section 10 shall be in addition to any liability
which the respective Underwriters may otherwise have and shall extend, upon the
same terms and conditions, to each officer and director of the Company and to
each person, if any, who controls the Company or any Selling Stockholder within
the meaning of the Act.

11.           If
any Underwriter shall default in its obligation to purchase the Shares which it
has agreed to purchase hereunder, you may in your discretion arrange for you or
another party or other parties to purchase such Shares on the terms contained
herein.  If within thirty-six hours
after such default by any Underwriter you do not arrange for the purchase of
such Shares, then the Selling Stockholders shall be entitled to a further
period of thirty-six hours within which to procure another party or other
parties satisfactory to you to purchase such Shares on such terms.  In the event that, within the respective
prescribed periods, you notify the Selling Stockholders that you have so
arranged for the purchase of such Shares, or the Selling Stockholders notify
you that they have so arranged for the purchase of such Shares, you or the
Selling Stockholders shall have the right to postpone the Time of Delivery for
a period of not more than seven days, in order to effect whatever changes may
thereby be made necessary in the Registration Statement or the Prospectus, or
in any other documents or arrangements, and the Company agrees to file promptly
any amendments to the Registration Statement or the Prospectus which in your
opinion may thereby be made necessary. 
The term “Underwriter” as used in this Agreement shall include any
person substituted under this Section with like effect as if such person had
originally been a party to this Agreement with respect to such Shares.

(b)           If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting
Underwriter or Underwriters by you and the Selling Stockholders as provided in
subsection (a) above, the aggregate number of such Shares which remains
unpurchased does not exceed one-eleventh of the aggregate number of all
the Shares, then the Selling Stockholders shall have the right to require each
non-defaulting Underwriter to purchase the number of Shares which such
Underwriter agreed to purchase hereunder and, in addition, to require each non-defaulting
Underwriter to purchase its pro rata share (based on the number of Shares which
such Underwriter agreed to purchase hereunder) of the Shares of such 

 24
 

 

defaulting Underwriter or Underwriters for which such
arrangements have not been made; but nothing herein shall relieve a defaulting
Underwriter from liability for its default.

(c)           If,
after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by you and the Selling Stockholders as
provided in subsection (a) above, the aggregate number of such Shares which
remains unpurchased exceeds one-eleventh of the aggregate number of all
of the Shares, or if the Selling Stockholders shall not exercise the right
described in subsection (b) above to require non-defaulting Underwriters
to purchase Shares of a defaulting Underwriter or Underwriters, then this
Agreement shall thereupon terminate, without liability on the part of any non-defaulting
Underwriter or the Company or the Selling Stockholders, except for the expenses
to be borne by the Company and the Selling Stockholders and the Underwriters as
provided in Section 8 hereof and the indemnity and contribution agreements in
Section 10 hereof; but nothing herein shall relieve a defaulting Underwriter
from liability for its default.

12.           The
respective indemnities, agreements, representations, warranties and other
statements of the Company, the Selling Stockholders and the several
Underwriters, as set forth in this Agreement or made by or on behalf of them,
respectively, pursuant to this Agreement, shall remain in full force and
effect, regardless of any investigation (or any statement as to the results
thereof) made by or on behalf of any Underwriter or any controlling person of
any Underwriter, or the Company, or any of the Selling Stockholders, or any officer
or director or controlling person of the Company, or any controlling person of
any Selling Stockholder, and shall survive delivery of and payment for the
Shares.

13.           If
this Agreement shall be terminated pursuant to Section 11 hereof, neither the
Company nor the Selling Stockholders shall then be under any liability to any
Underwriter except as provided in Sections 8 and 10 hereof; but, if for any
other reason any Shares are not delivered by or on behalf of the Selling
Stockholders as provided herein, each of the Selling Stockholders pro rata
(based on the number of Shares to be sold by such Selling Stockholder
hereunder) will reimburse the Underwriters through you for all out-of-pocket
expenses approved in writing by you, including fees and disbursements of
counsel, reasonably incurred by the Underwriters in making preparations for the
purchase, sale and delivery of the Shares, but the Company and the Selling
Stockholders shall then be under no further liability to any Underwriter  except as provided in Sections 8 and 10
hereof.

14.           In
all dealings hereunder, you shall act on behalf of each of the Underwriters,
and the parties hereto shall be entitled to act and rely upon any statement,
request, notice or agreement on behalf of any Underwriter made or given by you.

All statements, requests, notices and agreements
hereunder shall be in writing, and if to the Underwriters shall be delivered or
sent by mail, telex or facsimile transmission to you as the Representative at
One New York Plaza, 42nd Floor, New York, New York 10004, Attention:
Registration Department; if to any Selling Stockholder shall be delivered or
sent by mail, telex or facsimile transmission to counsel for such Selling
Stockholder at its address set forth in Schedule II hereto; and if to the Company
shall be delivered or sent by mail, telex or facsimile transmission to the
address of the Company set forth in the Registration Statement,

 25
 

 

Attention: Secretary; provided, however, that any
notice to an Underwriter pursuant to Section 9(c) hereof shall be delivered or
sent by mail, telex or facsimile transmission to such Underwriter at its
address set forth in its Underwriters’ Questionnaire, or telex constituting
such Questionnaire, which address will be supplied to the Company by you upon
request.  Any such statements, requests,
notices or agreements shall take effect upon receipt thereof.

15.           This
Agreement shall be binding upon, and inure solely to the benefit of, the
Underwriters, the Company and the Selling Stockholders and, to the extent provided
in Sections 10 and 12 hereof, the officers and directors of the Company and
each person who controls the Company, any Selling Stockholder or any
Underwriter, and their respective heirs, executors, administrators, successors
and assigns, and no other person shall acquire or have any right under or by
virtue of this Agreement.  No purchaser
of any of the Shares from any Underwriter shall be deemed a successor or assign
by reason merely of such purchase.

16.           Each
of the parties hereto irrevocably (i) agrees that any legal suit, action or
proceeding arising out of or based upon this Agreement or the transactions
contemplated hereby may be instituted in any state or federal court located in
the Borough of Manhattan, The City of New York, New York (a “New York Court”),
(ii) waives, to the fullest extent it may effectively do so, any objection
which it may now or hereafter have to the laying of venue of any such
proceeding and (iii) submits to the exclusive jurisdiction of such courts in
any such suit, action or proceeding. 
Each of the Selling Stockholders has appointed Hutchison Whampoa Agents
(US) Inc., New York, New York, as its authorized agent, (the “Authorized Agent”)
upon whom process may be served in any such action arising out of or based on
this Agreement or the transactions contemplated hereby which may be instituted
in any New York Court by any Underwriter or by any person who controls any
Underwriter, expressly consents to the jurisdiction of any such court in
respect of any such action, and waives any other requirements of or objections
to personal jurisdiction with respect thereto. 
The Company and each of the Selling Stockholders may replace the
Authorized Agent subject to the prior written consent of the Representative,
provided that there must at all times be an Authorized Agent appointed and such
appointment must be effective.  Each of
the Company and the Selling Stockholders represents and warrants that the
Authorized Agent has agreed to act as such agent for service at process and
agrees to take any and all action, including the filing of any and all
documents and instruments that may be necessary to continue such appointment in
full force and effect as aforesaid. 
Service of process upon the Authorized Agent and written notice of such
service to the Company or any of the Selling Stockholders, as the case may be,
shall be deemed, in every respect, effective service of process upon the
Company or any of the Selling Stockholders, as the case may be.

17.           In
respect of any judgment or order given or made for any amount due hereunder
that is expressed and paid in a currency (the “judgment currency”) other than
United States dollars, the Company or the Selling Stockholders, as the case may
be, will indemnify each Underwriter against any loss incurred by such
Underwriter as a result of any variation as between (i) the rate of exchange at
which the United States dollar amount is converted into the judgment currency
for the purpose of such judgment or order and (ii) the rate of exchange at
which an Underwriter is able to purchase United States dollars with the amount
of the

 26
 

 

judgment currency actually received by such
Underwriter.  The foregoing indemnity
shall constitute a separate and independent obligation of the Company and each
of the Selling Stockholders and shall continue in full force and effect
notwithstanding any such judgment or order as aforesaid.  The term “rate of exchange” shall include any
premiums and costs of exchange payable in connection with the purchase of or
conversion into United States dollars.

18.           Time
shall be of the essence of this Agreement. 
As used herein, the term “business day” shall mean any day when the
Commission’s office in Washington, D.C. is open for business.

19.           The
Company and the Selling Stockholders acknowledge and agree that (i) the
purchase and sale of the Shares pursuant to this Agreement is an arm’s-length
commercial transaction between the Company and the Selling Stockholders, on the
one hand, and the several Underwriters, on the other, (ii) in connection
therewith and with the process leading to such transaction each Underwriter is
acting solely as a principal and not the agent or fiduciary of the Company or
the Selling Stockholders, (iii) no Underwriter has assumed an advisory or
fiduciary responsibility in favor of the Company or the Selling Stockholders
with respect to the offering contemplated hereby or the process leading thereto
(irrespective of whether such Underwriter has advised or is currently advising
the Company or Selling Stockholders on other matters) or any other obligation
to the Company or Selling Stockholders except the obligations expressly set
forth in this Agreement and (iv) the Company and the Selling Stockholders have
consulted their own legal and financial advisors to the extent they deemed appropriate.  The Company and the Selling Stockholders
agree that they will not claim that the Underwriters, or any of them, has
rendered advisory services of any nature or respect, or owes a fiduciary or
similar duty to the Company or Selling Stockholders, in connection with such
transaction or the process leading thereto.

20.           This
Agreement supersedes all prior agreements and understandings (whether written
or oral) between the Company, the Selling Stockholders and the Underwriters, or
any of them, with respect to the subject matter hereof.

21.          This Agreement shall be governed by
and construed in accordance with the laws of the State of New York.

22.           The
Company, the Selling Stockholders and each of the Underwriters hereby
irrevocably waives, to the fullest extent permitted by applicable law, any and
all right to trial by jury in any legal proceeding arising out of or relating
to this Agreement or the transactions contemplated hereby.

23.             Notwithstanding anything herein to the
contrary, the Company and the Selling Stockholders are authorized to disclose
to any persons U.S. federal and state tax treatment and tax structure of the
potential transaction and all materials of any kind (including tax opinions and
other tax analyses) provided to the Company or the Selling Stockholders
relating to that treatment and structure, without the Underwriters imposing any
limitation of any kind. However, any information relating to the tax treatment
and tax structure shall remain confidential (and the foregoing sentence shall
not apply) to the extent necessary to

 27
 

 

enable any person to
comply with securities laws. For this purpose, “tax structure” is limited to
any facts that may be relevant to that treatment.”

 28

 

 

If
the foregoing is in accordance with your understanding, please sign and return
to us (one for the Company and the Representative plus one for each counsel)
counterparts hereof, and upon the acceptance hereof by you, on behalf of each
of the Underwriters, this letter and such acceptance hereof shall constitute a
binding agreement among each of the Underwriters, the Company and each of the
Selling Stockholders.  It is understood
that your acceptance of this letter on behalf of each of the Underwriters is pursuant
to the authority set forth in a form of Agreement among Underwriters, the form
of which shall be submitted to the Company and the Selling Stockholders for
examination, upon request, but without warranty on your part as to the
authority of the signers thereof.

	
  

  	
   

  
	
  

  	
  Very truly yours,

  
	
   

  	
   

  	
   

  
	
   

  	
  priceline.com Incorporated

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Jeffery H. Boyd

  
	
   

  	
   

  	
  Name: Jeffery H. Boyd

  
	
   

  	
   

  	
  Title: President, Chief Executive Officer

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Ultimate Pioneer Limited

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Frank J. Sixt

  
	
   

  	
   

  	
  Name: Frank J. Sixt

  
	
   

  	
   

  	
  Title: Director

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Potton Resources Limited

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Frank J. Sixt

  
	
   

  	
   

  	
  Name: Frank J. Sixt

  
	
   

  	
   

  	
  Title: Authorized Signatory

  

 

 

 

	
  Accepted as of the date
  hereof:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Goldman,
  Sachs & Co.

  	
   

  	
   

  
	
   

  
	
  By:

  	
  /s/ Goldman, Sachs & Co.

  	
   

  
	
   

  	
  (Goldman, Sachs & Co.)

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  On behalf of each of the Underwriters

  	
   

  
					

[Underwriting Agreement]

SCHEDULE
I

	
  Underwriter

  	
   

  	
  Number of

  Shares

  to be Purchased

  	
   

  
	
  Goldman, Sachs &
  Co.

  	
   

  	
  3,824,812

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Total

  	
   

  	
  3,824,812

  	
   

  

 

 F-1
 

SCHEDULE
II

	
  Selling Stockholders

  	
   

  	
  Total Number of

  Shares

  to be Sold

  	
   

  	
  Address of the Selling

  Stockholder

  	
   

  
	
  Ultimate Pioneer
  Limited

  	
   

  	
  1,912,406

  	
   

  	
  PO
  Box 957, Offshore

  Incorporations Centre, Road Town, 

  Tortola, British Virgin Islands

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Potton Resources
  Limited

  	
   

  	
  1,912,406

  	
   

  	
  PO
  Box 957, Offshore

  Incorporations Centre, Road Town, 

  Tortola, British Virgin Islands

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Total

  	
   

  	
  3,824,812

  	
   

  	
   

  	
   

  

 

 F-2
 

SCHEDULE III

(a)           Issuer Free Writing Prospectuses:

None

(b)           Additional Documents Incorporated by
Reference:

None

 F-3
 

SCHEDULE IV

SUBSIDIARIES

1.               Lowestfare.com Incorporated

2.               Travelweb LLC

3.               priceline.com International Ltd.

4.               priceline.com Europe Holdings N.V.

5.               priceline.com Europe Ltd.

6.               Priceline.com Europe Holdco, Inc.

7.               Priceline.com Holdco U.K. Limited

8.               Active Hotels Ltd.

9.               Bookings B.V.

 F-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]